![The World Congress on Controversies in Obstetrics, Gynecology and Infertility (COGI). Click here to learn more.]({"type":"image" , "src" : "/sda/112382/JournalAd-COGI2024-Leaderboard.jpg"})
References
- Crowley P. 2000. Prophylactic corticosteroids for preterm birth. Cochrane Database of Systematic Reviews (2):CD000065.
- Honest H, Bachmann LM, Gupta JK, Kleijnen J, Khan KS. 2002. Accuracy of cervicovaginal fetal fibronectin test in predicting spontaneous preterm birth: systematic review. British Medical Journal 325:301–304.
- Iams JD, Casal D, McGregor JA, Goodwin TM, Kreaden US, Lowensohn R et al. 1995. Fetal fibronectin improves the accuracy of diagnosis of preterm labour. American Journal of Obstetrics and Gynecology 173:141–145.
- Joffe GM, Jacques D, Bemis-Heys R, Burton R, Skram B, Shelburne P. 1999. Impact of the fetal fibronectin assay on admissions for preterm labour. American Journal of Obstetrics and Gynecology 180:581–586.
- Lockwood CJ, Senyei AE, Dische MR, Casal D, Shah KD, Thung SN et al. 1991. Fetal fibronectin in cervical and vaginal secretions as a predictor of preterm delivery. New England Journal of Medicine 325:669–674.
- Mahony R, McKeating A, Murphy T, McAuliffe F, O’Herlihy C, Foley M. 2010. Appropriate antenatal corticosteroids use women at risk of preterm birth before 34 weeks of gestation. British Journal of Obstetrics and Gynaecology 117:963–967.
- Marlow N, Wolke D, Bracewell M, Samara M. 2005. EPICure Study Group. Neurologic and developmental disability at six years of age after extremely preterm birth. New England Journal of Medicine 352:9–19.
- Matsuura H, Hakomori S. 1985. The oncofetal domain of fibronectin defined by monoclonal antibody FDC-6: its presence in fibronectins from fetal and tumour tissues and its absence in those from normal adult tissues and plasma. Proceedings of the National Academy of Sciences of the USA 82:6517–6521.
- NHS. 2011. Hospital episode statistics: NHS maternity statistics 2010–2011. Health and London: Social Care Information Centre. Available at: www.hesonline.nhs.uk/Ease/servlet/ContentServer?siteID = 1937.
- Parker J, Bell R, Brennecke S. 1995. Fetal fibronectin in the cervicovaginal fluid of women with threatened preterm labour as a predictor of delivery before 34 weeks’ gestation. Australian and New Zealand Journal of Obstetrics and Gynaecology 35:257.
- Peaceman AM, Andrews WW, Thorp JM, Cliver SP, Lukes A, Iams JD et al. 1997. Fetal fibronectin as a predictor of preterm birth in patients with symptoms: a multicenter trial. American Journal of Obstetrics and Gynecology 177:13–18.
- Sanchez-Ramos L, Delke I, Zamora J, Kaunitz AM. 2009. Fetal fibronectin as a short-term predictor of preterm birth in symptomatic patients: a meta-analysis. Obstetrics and Gynecology 114:631.
- Sibille Y, Lwebuga-Mukasa JS, Polomski L, Merrill WW, Ingbar DH, Gee JB. 1986. An in vitro model for polymorphonuclear-leukocyte-induced injury to an extracellular matrix. Relative contribution of oxidants and elastase to fibronectin release from amnionic membranes. American Review of Respiratory Disease 134:134–140.